Nov 18, 2019 · Novartis is calling it curtains on early drug discovery at its R&D site in Shanghai in a companywide move to “rebalance” its discovery and early development efforts.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

诺华中国. 上海市浦东新区张江高科技园区金科路4218号 总机：021-61606000 邮政编码：201203

Jan 7, 2024 · Under the first agreement, Argo has granted Novartis exclusive global licenses to develop and commercialize a Phase 1 stage program. The first agreement also includes a …

Dec 28, 2020 · In 2016, Novartis Shanghai Campus had its Phase I construction completed, with a total of seven buildings. Our plan emphasises on the spatial quality of the campus, and the …

Fostering creativity, reflection, communication and interchange: a procession of choreographed spaces that weave together Chinese landscape traditions, undulating topography, and …

Nov 18, 2019 · Novartis is halting early-stage research in Shanghai and shifting the site's focus to commercial development three years after the Swiss drugmaker christened the new $1 billion …

Novartis announced plans to build an integrated biomedical Research & Development center in Shanghai's Zhangjiang Hi-Tech Park. The establishment of this site is a commitment by …

Shanghai Novartis Trading Ltd., 14th floor, China World Tower 2, No.1 Jian Guo Men Wai Avenue, Chao Yang District, Beijing 100004, China. Web: https://www.novartis.com.cn. …

Nov 6, 2024 · With full confidence in China, where Novartis recorded 17 percent growth last year, one of the fastest among all major multinational pharmaceutical companies, the top China …